JLABS 5 Year Anniversary Impact Report Statistics from JLABS 5 Year Anniversary Related content Related video JLABS @ NYC Launch Related article Syndesi Therapeutics Awarded Non-dilutive Funding of up to €3.2M for Development of its Lead Program, SDI-118, Aimed at Treating Cognitive Impairment TAGS JLABS Impact Paul Stoffels
Syndesi Therapeutics Awarded Non-dilutive Funding of up to €3.2M for Development of its Lead Program, SDI-118, Aimed at Treating Cognitive Impairment
